Related Research Articles
Mefloquine, sold under the brand name Lariam among others, is a medication used to prevent or treat malaria. When used for prevention it is typically started before potential exposure and continued for several weeks after potential exposure. It can be used to treat mild or moderate malaria but is not recommended for severe malaria. It is taken by mouth.
Sir Ronald Ross was a British medical doctor who received the Nobel Prize for Physiology or Medicine in 1902 for his work on the transmission of malaria, becoming the first British Nobel laureate, and the first born outside Europe. His discovery of the malarial parasite in the gastrointestinal tract of a mosquito in 1897 proved that malaria was transmitted by mosquitoes, and laid the foundation for the method of combating the disease.
Charles Louis Alphonse Laveran was a French physician who won the Nobel Prize in Physiology or Medicine in 1907 for his discoveries of parasitic protozoans as causative agents of infectious diseases such as malaria and trypanosomiasis. Following his father, Louis Théodore Laveran, he took up military medicine as his profession. He obtained his medical degree from University of Strasbourg in 1867.
Tropical diseases are diseases that are prevalent in or unique to tropical and subtropical regions. The diseases are less prevalent in temperate climates, due in part to the occurrence of a cold season, which controls the insect population by forcing hibernation. However, many were present in northern Europe and northern America in the 17th and 18th centuries before modern understanding of disease causation. The initial impetus for tropical medicine was to protect the health of colonial settlers, notably in India under the British Raj. Insects such as mosquitoes and flies are by far the most common disease carrier, or vector. These insects may carry a parasite, bacterium or virus that is infectious to humans and animals. Most often disease is transmitted by an insect bite, which causes transmission of the infectious agent through subcutaneous blood exchange. Vaccines are not available for most of the diseases listed here, and many do not have cures.
The Liverpool School of Tropical Medicine (LSTM) is a higher education institution with degree awarding powers and registered charity located in Liverpool, United Kingdom. Established in 1898, it was the first institution in the world dedicated to research and teaching in tropical medicine. The school has a research portfolio of over £220 million, assisted by funding from organisations such as the Bill & Melinda Gates Foundation, Wellcome Trust and Department for International Development (DFID).
Travel medicine or emporiatrics is the branch of medicine that deals with the prevention and management of health problems of international travelers.
Endel Tulving was an Estonian-born Canadian experimental psychologist and cognitive neuroscientist. In his research on human memory he proposed the distinction between semantic and episodic memory. Tulving was a professor at the University of Toronto. He joined the Rotman Research Institute at Baycrest Health Sciences in 1992 as the first Anne and Max Tanenbaum Chair in Cognitive Neuroscience and remained there until his retirement in 2010. In 2006, he was named an Officer of the Order of Canada (OC), Canada's highest civilian honour.
Primaquine is a medication used to treat and prevent malaria and to treat Pneumocystis pneumonia. Specifically it is used for malaria due to Plasmodium vivax and Plasmodium ovale along with other medications and for prevention if other options cannot be used. It is an alternative treatment for Pneumocystis pneumonia together with clindamycin. It is taken by mouth.
Proguanil, also known as chlorguanide and chloroguanide, is a medication used to treat and prevent malaria. It is often used together with chloroquine or atovaquone. When used with chloroquine the combination will treat mild chloroquine resistant malaria. It is taken by mouth.
Joseph Louis Rotman,, was a noted Canadian businessman and philanthropist. Rotman was the founder, benefactor and member of many successful organizations, such as the Clairvest Group Inc., the Rotman Research Institute, the Rotman School of Management, and the Rotman Institute of Philosophy. Throughout his life, he received three honorary degrees, as well as an induction into the Canadian Business Hall of Fame. He is well-regarded for donating his time and financial assistance to numerous philanthropic causes including the arts, education and healthcare.
Brigadier Sir Neil Hamilton Fairley, was an Australian physician, medical scientist, and army officer who was instrumental in saving thousands of Allied lives from malaria and other diseases.
Peter Alexander Singer, OC, FRSC, is special advisor to the director general of the World Health Organization, and also adjunct professor of medicine at University of Toronto.
Sir Gordon Covell was a physician and a major general in the Indian Medical Service. He specialized in malaria disease control and eradication efforts and was a member of the expert committee on malaria set up by the WHO from 1948 to 1958, serving as its secretary. He was also an advisor to the British Ministry of Health and the Director of the Malaria Laboratory at Horton Hospital.
Dr. Abdallah Daar is an Emeritus Professor of Clinical Public Health, Global Health, and Surgery at the University of Toronto. He has also been a Senior Scientist at the Research Institutes of University Health Network/Toronto General Hospital Research Institute, and the Hospital for SickKids. At the University of Toronto Joint Centre for Bioethics, from 2001 to 2007, he was co-director of the Canadian Program on Genomics and Global Health, and Director of the University of Toronto Program in Applied Ethics and Biotechnology. At the Sandra Rotman Centre, he was Director of Ethics and Commercialization.
Sandra Ann Rotman,, is a Canadian philanthropist and community leader.
William George MacCallum was a Canadian-American physician and pathologist. He was of Scottish descent and was born in Dunnville village in Canada, where his father was a physician. He was educated at the University of Toronto. He graduated with BA in 1894. Initially inclined towards Greeks as academic career, his father influenced him to enter medicine. He joined the second year of the first batch of medicine course in the Johns Hopkins Medical School, and became one of the first graduates of the institute in 1897. He was appointed assistant resident of pathology of the medical school in 1897, resident pathologist in 1901, soon after Associate Professor, and full Professor in 1908. Between 1909 and 1917 he held a twin position of Professor of Pathology at Columbia University and the NewYork–Presbyterian Hospital. From 1917 to 1943 he held the Chair of Pathogy at Johns Hopkins University.
Peter Gottfried Kremsner is a specialist in tropical medicine and Full Professor at the University of Tübingen, Germany. Since 1992 he has been leading the Centre de Recherches Médicales de Lambaréné (CERMEL), Gabon, now as president.
Nicholas John White is a British medical doctor and researcher, specializing in tropical medicine in developing countries. He is known for his work on tropical diseases, especially malaria using artemisinin-based combination therapy.
Michele Barry is a professor of medicine. She became Stanford's inaugural Senior Associate Dean of global health in 2009 and started the Stanford Center for Innovation in Global Health in 2010. Prior to this, she was a professor at Yale, where she started the first refugee health clinic and homeless health mobile van project, for which she was awarded the Elm Ivy Mayor’s Award. She specializes in tropical medicine, emerging infectious diseases, women’s leadership in global health, and human and planetary health.
Dr. Winnie Mpanju-Shumbusho is a Tanzanian paediatrician and public health leader who until December 31, 2015, served as World Health Organization (WHO) Assistant Director General for HIV/AIDS, Tuberculosis, Malaria and Neglected Tropical Diseases based in Geneva, Switzerland. From 2016 to 2019, she served as board chair of RBM Partnership To End Malaria. Before joining WHO in 1999, Mpanju-Shumbusho was Director General of The East, Central and Southern African Health Community (ECSA-HC) formerly known as the Commonwealth Regional Health Community for East, Central and Southern Africa (CRHC-ECSA).